कंपनी का अवलोकन
HCA Healthcare, Inc. operates as a comprehensive provider of healthcare services across the United States, owning and managing hospitals, ambulatory surgery centers, emergency care facilities, urgent care clinics, and diagnostic imaging centers. The company functions within the Healthcare sector, specifically the Medical Care Facilities industry, positioning it as a critical infrastructure entity for patient care and medical operations. As of the latest available data, HCA commands a substantial market capitalization of $113.42B and generates annual revenue of $75.60B, supported by a workforce of 230,000 employees. These valuation and revenue figures indicate that the organization is a massive market leader with significant scale, allowing it to influence healthcare delivery standards and maintain a dominant presence in the national medical landscape.
वित्तीय स्वास्थ्य
The company reports a trailing twelve-month revenue of $75.60B, with a corresponding net income of $6.78B and EBITDA of $15.49B. The substantial gap between the $75.60B revenue and $6.78B net income highlights a cost structure where operating expenses, including salaries, supplies, and overhead, consume approximately 91% of total revenue before arriving at the bottom line. Free cash flow stands at $5.82B, which provides the entity with significant financial flexibility to fund capital expenditures, service acquisitions, or manage liquidity needs without immediate reliance on external financing. Regarding profitability efficiency, the gross margin is 41.5%, the operating margin is 16.3%, and the profit margin is 9.0%, indicating that while the cost of goods sold is moderate, operational and administrative costs significantly impact the final bottom-line retention. The balance sheet shows total debt of $48.70B against total cash reserves of $1.14B, resulting in a debt-to-equity ratio listed as N/A due to the specific accounting presentation of equity in this context. This leverage profile suggests a capital-intensive model where debt is utilized extensively to finance the high fixed-asset base of hospitals and facilities. Short-term liquidity is measured by a current ratio of 0.96, which indicates that current assets fall slightly short of covering current liabilities, a common characteristic in capital-heavy industries where long-term debt servicing exceeds immediate current obligations. Return on assets is recorded at 12.4%, while return on equity is listed as N/A, revealing that the company generates efficient asset utilization relative to its total asset base despite the complexities in calculating equity returns given the high leverage structure.
मूल्यांकन आकलन
Valuation metrics for HCA include a trailing P/E ratio of 17.89 and a forward P/E of 15.24, where the lower forward multiple implies that the market expects earnings growth to accelerate in the coming fiscal periods relative to current performance. The price-to-book ratio is -18.90, a negative figure that indicates the market valuation does not align with traditional book value accounting due to the capital-intensive nature of the business and potential non-operating asset classifications. Alternative valuation measures include a price-to-sales ratio of 1.50 and an EV/EBITDA of 10.60, suggesting the market values the company at a premium relative to sales but at a reasonable multiple of its earnings before interest, taxes, depreciation, and amortization. The stock has a 52-week high of $556.52 and a 52-week low of $314.43, meaning the current trading price sits within this historical range, reflecting recent market volatility and investor sentiment regarding the healthcare sector's resilience. The beta value is 1.37, which signifies that the stock price is more volatile than the broader market, moving 37% more aggressively than the general market index during periods of rising or falling equity prices.
Growth & Income
Revenue growth year-over-year is 6.7%, while earnings growth year-over-year is 44.5%, demonstrating that earnings are expanding at a rate significantly faster than revenue, likely driven by operational leverage and margin expansion initiatives. The company offers a dividend yield of 0.6% with a payout ratio of 10.2%, indicating that the dividend is highly sustainable as it covers only a small fraction of the generated earnings. Given the high earnings growth rate relative to revenue, the company retains the majority of its profits to reinvest in network expansion and technology upgrades rather than distributing them fully to shareholders. The overall profile combines steady double-digit earnings growth with a low-yield dividend, characteristic of a growth-oriented healthcare operator that prioritizes capital deployment for organic expansion and inorganic acquisitions over maximizing current income distributions.